Current Liabilities
Sales Rebates and Discounts
Eli Lilly Sales Rebates and Discounts increased by 0.9% to $17.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 51.9%, from $11.55B to $17.55B. Over 5 years (FY 2020 to FY 2025), Sales Rebates and Discounts shows an upward trend with a 24.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase may signal higher competitive pressure or a shift in sales mix toward high-volume, lower-margin channels.
Detailed definition
This represents accrued liabilities for estimated rebates, volume discounts, and chargebacks owed to customers based on...
Peer comparison
Highly relevant for pharmaceutical and medical device companies; peers often disclose this as a significant deduction from gross sales.
Metric ID:
sales_rebates_and_discountsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.04B | $7.19B | $6.85B | $6.77B | $7.99B | $8.57B | $8.78B | $9.53B | $10.39B | $11.52B | $11.69B | $9.43B | $12.45B | $12.43B | $11.54B | $11.55B | $14.54B | $17.62B | $17.38B | $17.55B |
| QoQ Change | — | +2.1% | -4.7% | -1.1% | +18.1% | +7.2% | +2.5% | +8.5% | +9.0% | +10.9% | +1.4% | -19.3% | +32.0% | -0.1% | -7.2% | +0.1% | +25.9% | +21.2% | -1.4% | +0.9% |
| YoY Change | — | — | — | — | +13.6% | +19.2% | +28.3% | +40.8% | +30.0% | +34.5% | +33.1% | -1.0% | +19.8% | +7.9% | -1.3% | +22.5% | +16.8% | +41.8% | +50.6% | +51.9% |
Range$6.77B – $17.62B
CAGR+21.2%
Avg YoY Growth+25.5%
Median YoY Growth+25.4%
Sales Rebates and Discounts at Other Companies
Frequently Asked Questions
- What is Eli Lilly's sales rebates and discounts?
- Eli Lilly (LLY) reported sales rebates and discounts of $17.55B in Q1 2026.
- How has Eli Lilly's sales rebates and discounts changed year-over-year?
- Eli Lilly's sales rebates and discounts increased by 51.9% year-over-year, from $11.55B to $17.55B.
- What is the long-term trend for Eli Lilly's sales rebates and discounts?
- Over 5 years (2020 to 2025), Eli Lilly's sales rebates and discounts has grown at a 24.3% compound annual growth rate (CAGR), from $5.85B to $17.38B.
- What does sales rebates and discounts mean?
- Accrued costs for discounts and rebates promised to customers for their purchases.